109 related articles for article (PubMed ID: 8669661)
1. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia.
Van Heerden PV; Webb SA; Hee G; Corkeron M; Thompson WR
Anaesth Intensive Care; 1996 Feb; 24(1):87-90. PubMed ID: 8669661
[TBL] [Abstract][Full Text] [Related]
2. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS.
van Heerden PV; Barden A; Michalopoulos N; Bulsara MK; Roberts BL
Chest; 2000 Mar; 117(3):819-27. PubMed ID: 10713012
[TBL] [Abstract][Full Text] [Related]
3. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
Van Heerden PV; Blythe D; Webb SA
Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
[TBL] [Abstract][Full Text] [Related]
4. The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
Searcy RJ; Morales JR; Ferreira JA; Johnson DW
Ther Adv Respir Dis; 2015 Dec; 9(6):302-12. PubMed ID: 26294418
[TBL] [Abstract][Full Text] [Related]
5. Re: Delivery of inhaled aerosolized prostacyclin (IAP).
van Heerden PV; Power BM; Leonard RC
Anaesth Intensive Care; 1996 Oct; 24(5):624-5. PubMed ID: 8909691
[No Abstract] [Full Text] [Related]
6. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.
Zwissler B; Kemming G; Habler O; Kleen M; Merkel M; Haller M; Briegel J; Welte M; Peter K
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1671-7. PubMed ID: 8970353
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.
Walmrath D; Schneider T; Schermuly R; Olschewski H; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1996 Mar; 153(3):991-6. PubMed ID: 8630585
[TBL] [Abstract][Full Text] [Related]
8. Description and evaluation of a delivery system for aerosolized prostacyclin.
Siobal MS; Kallet RH; Pittet JF; Warnecke EL; Kraemer RW; Venkayya RV; Tang JF
Respir Care; 2003 Aug; 48(8):742-53. PubMed ID: 12890294
[TBL] [Abstract][Full Text] [Related]
9. Systemic levels of 6-keto-prostaglandin F1 alpha following administration of inhaled aerosolized prostacyclin.
van Heerden PV
Anaesth Intensive Care; 1997 Dec; 25(6):701-3. PubMed ID: 9452859
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin.
Rocca GD; Coccia C; Pompei L; Ruberto F; Venuta F; De Giacomo T; Pietropaoli P
J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):224-7. PubMed ID: 11312484
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
12. Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS.
Ammar MA; Bauer SR; Bass SN; Sasidhar M; Mullin R; Lam SW
Ann Pharmacother; 2015 Oct; 49(10):1105-12. PubMed ID: 26187741
[TBL] [Abstract][Full Text] [Related]
13. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation.
Fiser SM; Cope JT; Kron IL; Kaza AK; Long SM; Kern JA; Tribble CG; Lowson SM
J Thorac Cardiovasc Surg; 2001 May; 121(5):981-2. PubMed ID: 11326243
[No Abstract] [Full Text] [Related]
15. Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
Afshari A; Brok J; Møller AM; Wetterslev J
Cochrane Database Syst Rev; 2010 Aug; (8):CD007733. PubMed ID: 20687093
[TBL] [Abstract][Full Text] [Related]
16. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
[TBL] [Abstract][Full Text] [Related]
17. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Tibballs J; Goh TH; McKenzie I; Hochmann M
Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
[No Abstract] [Full Text] [Related]
18. Severity of Hypoxemia and Other Factors That Influence the Response to Aerosolized Prostacyclin in ARDS.
Kallet RH; Burns G; Zhuo H; Ho K; Phillips JS; Pangilinan LP; Yip V; Gomez A; Lipnick MS
Respir Care; 2017 Aug; 62(8):1014-1022. PubMed ID: 28559468
[TBL] [Abstract][Full Text] [Related]
19. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
Barry PW
Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434
[No Abstract] [Full Text] [Related]
20. Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?
Puri N; Dellinger RP
Crit Care Clin; 2011 Jul; 27(3):561-87. PubMed ID: 21742217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
